Explore the development of vaccines and treatments for Bundibugyo Ebola amid the ongoing outbreak in the Democratic Republic of Congo.

Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.

With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions